Hikma to pay $115M in cash, $35M in donations to settle opioid claims
London-based Hikma Pharmaceuticals has reached an agreement to settle allegations brought against the company by US states and local governments for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
